Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Progress toward genetic tailoring of heart failure therapy.

Lillvis JH, Lanfear DE.

Curr Opin Mol Ther. 2010 Jun;12(3):294-304. Review.

2.

Pharmacogenetics in chronic heart failure: new developments and current challenges.

Talameh JA, Lanfear DE.

Curr Heart Fail Rep. 2012 Mar;9(1):23-32. doi: 10.1007/s11897-011-0076-2. Review.

3.

Genetic tailoring of pharmacotherapy in heart failure: optimize the old, while we wait for something new.

Talameh JA, McLeod HL, Adams KF Jr, Patterson JH.

J Card Fail. 2012 Apr;18(4):338-49. doi: 10.1016/j.cardfail.2012.01.002. Epub 2012 Feb 2. Review.

PMID:
22464776
4.

Pharmacogenomics of heart failure.

Lymperopoulos A, French F.

Methods Mol Biol. 2014;1175:245-57. doi: 10.1007/978-1-4939-0956-8_10.

PMID:
25150872
5.

Pharmacogenetics in heart failure: genomic markers of endothelial and neurohumoral function.

McNamara DM.

Congest Heart Fail. 2004 Nov-Dec;10(6):302-8. Review.

6.

Pharmacogenomics of heart failure: a systematic review.

Mottet F, Vardeny O, de Denus S.

Pharmacogenomics. 2016 Nov;17(16):1817-1858. Epub 2016 Nov 4. Review.

PMID:
27813451
7.

Heart failure pharmacogenetics: past, present, and future.

Davis HM, Johnson JA.

Curr Cardiol Rep. 2011 Jun;13(3):175-84. doi: 10.1007/s11886-011-0181-6. Review.

8.

Pharmacogenetics in heart failure: promises and challenges.

de Boer RA, van der Harst P, van Veldhuisen DJ, van den Berg MP.

Expert Opin Pharmacother. 2009 Aug;10(11):1713-25. doi: 10.1517/14656560903025171. Review.

PMID:
19558337
9.

Beta-blocker pharmacogenetics in heart failure.

Shin J, Johnson JA.

Heart Fail Rev. 2010 May;15(3):187-96. doi: 10.1007/s10741-008-9094-x. Epub 2008 Apr 24. Review.

10.

Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.

Ghali JK, Tam SW, Ferdinand KC, Lindenfeld J, Sabolinski ML, Taylor AL, Worcel M, Curry CL, Cohn JN; A-HeFT Investigators.

Am J Cardiovasc Drugs. 2007;7(5):373-80.

PMID:
18041162
11.

Chronic heart failure: beta-blockers and pharmacogenetics.

Azuma J, Nonen S.

Eur J Clin Pharmacol. 2009 Jan;65(1):3-17. doi: 10.1007/s00228-008-0566-7. Epub 2008 Oct 7. Review.

PMID:
18839161
12.

Genetic prediction of heart failure incidence, prognosis and beta-blocker response.

Filigheddu F.

Mol Diagn Ther. 2013 Aug;17(4):205-19. doi: 10.1007/s40291-013-0035-6. Review.

PMID:
23592012
13.

Treatment of heart failure with preserved systolic function.

de Groote P, Herpin D, Diévart F, Hanon O, Trochu JN, Artigou JY, Galinier M, Habib G, Juillière Y, Neuder Y, Roudaut R, Komajda M.

Arch Cardiovasc Dis. 2008 May;101(5):361-72. doi: 10.1016/j.acvd.2008.04.008. Epub 2008 Jul 7. Review.

14.

Advances in the treatment of heart failure with a preserved ejection fraction.

Das A, Abraham S, Deswal A.

Curr Opin Cardiol. 2008 May;23(3):233-40. doi: 10.1097/HCO.0b013e3282f73317. Review.

PMID:
18382212
15.

Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.

McNamara DM, Holubkov R, Janosko K, Palmer A, Wang JJ, MacGowan GA, Murali S, Rosenblum WD, London B, Feldman AM.

Circulation. 2001 Mar 27;103(12):1644-8.

16.

Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.

McMurray J, Cohen-Solal A, Dietz R, Eichhorn E, Erhardt L, Hobbs FD, Krum H, Maggioni A, McKelvie RS, Piña IL, Soler-Soler J, Swedberg K.

Eur J Heart Fail. 2005 Aug;7(5):710-21.

17.

Outpatient management of chronic heart failure.

Kaldara E, Sanoudou D, Adamopoulos S, Nanas JN.

Expert Opin Pharmacother. 2015 Jan;16(1):17-41. doi: 10.1517/14656566.2015.978286. Epub 2014 Dec 5. Review.

PMID:
25480690
18.
19.

Medication adherence to specific drug classes in chronic heart failure.

Viana M, Laszczynska O, Mendes S, Friões F, Lourenço P, Bettencourt P, Lunet N, Azevedo A.

J Manag Care Spec Pharm. 2014 Oct;20(10):1018-26.

20.

Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.

Dulin BR, Krum H.

Curr Opin Cardiol. 2006 Jul;21(4):393-9. Review.

PMID:
16755210

Supplemental Content

Support Center